Rivaroxaban as thromboprophylaxis improves clinical outcomes after COVID-19 hospitalization
For patients at high risk for venous thromboembolism (VTE) discharged after COVID-19 hospitalization, thromboprophylaxis with rivaroxaban is associated with improved ...
Read more